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Alcoholic fatty liver disease (AFLD) is characterized by lipid accumulation and inflammation and can progress to 
cirrhosis and cancer in the liver. AFLD diagnosis currently relies on histological analysis of liver biopsies. Early 
detection permits interventions that would prevent progression to cirrhosis or later stages of the disease. Herein, we 
have conducted the first comprehensive time- course study of lipids using novel state- of- the art lipidomics methods in 
plasma and liver in the early stages of a mouse model of AFLD, i.e., Lieber- DeCarli diet model. In ethanol- treated 
mice, changes in liver tissue included up- regulation of triglycerides (TGs) and oxidized TGs and down- regulation of 
phosphatidylcholine, lysophosphatidylcholine, and 20- 22- carbon- containing lipid- mediator precursors. An increase in 
oxidized TGs preceded histological signs of early AFLD, i.e., steatosis, with these changes observed in both the liver 
and plasma. The major lipid classes dysregulated by ethanol play important roles in hepatic inflammation, steatosis, and 
oxidative damage. Conclusion: Alcohol consumption alters the liver lipidome before overt histological markers of early 
AFLD. This introduces the exciting possibility that specific lipids may serve as earlier biomarkers of AFLD than those 
currently being used. (Hepatology Communications 2021;0:1-13).
Fatty liver disease or hepatosteatosis occurs when lipids accumulate in the liver as a result of dys-regulated lipid metabolism leading to increased 
lipogenesis, reduced lipolysis, and lipotoxicity.(1) 
Lipotoxicity may potentially elicit an inflammatory 
response that can lead to the progression to cirrho-
sis and hepatocellular carcinoma. Clinically, fatty 
liver disease can be divided into alcoholic (AFLD) 
and nonalcoholic fatty liver disease (NAFLD). Both 
AFLD and NAFLD are generally indistinguishable 
using only morphological evidence, other than the dis-
tinctions applied by these etiological designations.(2) 
Although the prevalence of NAFLD worldwide com-
pared to AFLD has been increasing exponentially 
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during the past decade due to the global obesity pan-
demic, attention to AFLD has been growing in recent 
years for a multitude of reasons.
The World Health Organization Global Status 
Report on Alcohol and Health 2018 reported an 
alarming 3 million deaths (5.3% of all deaths) and 
132.6 million disability- adjusted life years (DALYs) 
from harmful alcohol use in the year 2016(3); among 
them, alcohol- attributable liver cirrhosis caused a sig-
nificant 607,000 deaths and 22.2 million DALYs.(3) 
It has also become a more frequent cause of morbid-
ity and mortality globally, especially in developing 
countries.(4) Importantly, approximately half of liver 
cirrhosis- related deaths were attributable to alcohol 
use.(3) The global burden of alcohol- related liver dis-
ease is postulated to increase with increasing alcohol 
consumption. A large comprehensive survey con-
ducted in the United States since 2001 showed that 
alcohol use from 2001 to 2012 rose across all catego-
ries of alcohol use and all demographics. This rise was 
more pronounced in women, rural citizens, and those 
with lower socioeconomic status.(5)
Due to the high morbidity and mortality of advanced 
liver disease, detection of early stages of alcoholic liver 
disease (ALD) and development of new therapeutic 
agents are crucial. Currently, early forms of ALD are 
often missed and mostly detected during the stage of 
alcoholic hepatitis when they are clinically apparent.(6) 
Other than invasive liver biopsy, which has been the 
gold standard for diagnosis, no noninvasive techniques 
have been approved to diagnose the different stages of 
ALD.(7) Once diagnosed, treatment options are lim-
ited. Standard therapy for the past decades has not 
evolved.(6) In both early and severe ALD, prolonged 
abstinence is the most efficient therapeutic measure. 
Depending on the stages of ALD, steroids are used for 
alcoholic hepatitis and liver transplantation is needed 
at the end- stage disease.(6,8) This is further hampered 
by poor understanding of the pathophysiology of ALD.
Recent advances in the field of lipidomics has 
allowed for the global characterization of lipids at the 
molecular and systems level. This advancement has 
permitted the identification of toxic lipid species and 
the unique molecular signatures for specific liver dis-
ease.(1) Lipidomics analysis has been shown to discern 
stages of NAFLD.(1) However, no work to date has 
employed the state- of- the- art lipidomics techniques to 
determine changes in lipid profiles across time in the 
early stages of AFLD. In our study, we were interested 
in assessing the dynamic changes in lipid profile of 
early stages of AFLD across time to determine early 
stage indicators and mechanisms of fatty liver disease 
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progression. This technique is promising not only for 
the development of biomarkers for detection of early 
stages of AFLD and insights into the pathophysiology 
of AFLD but also for novel therapeutic intervention.
Materials and Methods
miCe stuDy
Twelve- week- old male C57BL/6J mice were fed a 
modified Lieber- DeCarli (LD) liquid diet containing 
ethanol (ethanol group E1- 3, n  =  7- 10) or the con-
trol LD diet in which ethanol was substituted iso-
calorically by maltose- dextrin (control group C1- 3, 
n  =  5- 7) for 5  weeks. The levels of ethanol in the 
AFLD diet started at 2% (volume [vol]/vol) and was 
increased by 1% weekly over the following 5  weeks 
(Fig. 1). The increased amount of ethanol replaced 
maltose isocalorically in the diet; therefore, the cal-
ories per unit volume liquid diet stayed the same 
throughout the feeding course. The control groups 
were pair fed such that they received the same amount 
of food (or calories) consumed by the ethanol groups. 
Calorie intake (kilocalories) was recorded (Supporting 
Table S2; Supporting Fig. S9), and after adjusting the 
P value using the Benjamini- Hochberg correction, 
no differences between ethanol- fed and control mice 
were observed (false discovery rate [FDR] corrected 
P  <  0.05); however, calorie intake in weeks 3- 5 was 
slightly higher in control- fed mice and approaching 
significance. Livers were harvested on weeks 0 (chow), 
2 (GE1, GC1), 4 (GE2, GC2), and 5 (GE3, GC3) 
(Fig. 1), and untargeted lipidomics was performed.
HistopatHology
A section of the liver from each mouse was pro-
cessed for hematoxylin and eosin staining using stan-
dard procedures and examined by an experienced 
pathologist blinded to the study. Score averages, SDs, 
and P values were determined using the two- sided, 
unpaired, or unequal variance Student t test.
lipiDomiCs
Liver and plasma samples were extracted using the 
Bligh- Dyer extraction method.(9) Liquid chromatography 
Fig. 1. Scheme of treatment regime. Male C57BL/6J mice (10- 12 weeks old) were randomly divided into seven groups. The chow group 
was fed standard rodent chow. EtOH groups (GE1, GE2, GE3) and pair- fed control groups (GC1, GC2, GC3) were fed a modified LD 
diet for up to 5 weeks. GE groups started with an LD diet containing 2% EtOH vol/vol with a weekly increase of 1% EtOH (vol/vol) 
until it reached 5% (vol/vol). GC groups received an LD diet (CON) in which the EtOH content was substituted by carbohydrates. On 
day 6- 7 (3 pm to 9 am) of week 2 (GE1 and GC1), week 4 (GE2 and GC2), or week 5 (GE3 and GC3), mice were placed singly in a 
metabolic cage with free access to the corresponding LD diet for 18 hours and then subjected to 4 hours fasting in regular housing cages 
before being euthanized. Abbreviations: CON, control; EtOH, ethanol.
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was performed on an ultra- high- performance liq-
uid chromatography (UHPLC) system (Vanquish; 
Thermo Scientific, San Jose, CA) using a C30 column 
(2.1 × 150 mm, 2.6 μm particle size) (Accucore; Thermo 
Scientific) and a gradient program consisting of mobile 
phase A (60:40 acetonitrile/water) and mobile phase 
B (90:10 isopropanol/acetonitrile), each containing 
5 mmol/L ammonium formate and 0.1% (vol/vol) for-
mic acid. The UHPLC system was coupled to a mass 
spectrometer (Q- Exactive Orbitrap; Thermo Scientific) 
for chromatographic separation and mass spectral mea-
surement of lipids in positive and negative ion mode, 
respectively, using full- scan and iterative exclusion(10,11) 
tandem mass spectrometry. The software LipidMatch 
Flow(12) was deployed for peak picking, blank filtering, 
annotation, and combining positive and negative ion 
polarity, whereas LipidMatch Normalizer(13) was used 
for semiquantitation. Novel oxidized lipidomics librar-
ies were developed and applied as reported.(14) Extensive 
details on software development, deployment, and acqui-
sition methods can be found in the Supporting Material.
Results
Although current state- of- the- art lipidomics tech-
nology can only provide estimated lipid concentra-
tions using class- based standards, as has been done 
here, these relative concentrations are sufficient for 
determining lipid fold changes.(15) Further discussion 
on lipid normalization is discussed in depth else-
where.(13,16) Significant changes across nearly all lipid 
classes were observed for alcohol- fed mice both across 
time and in relation to the controls (Fig. 2).
time- anD Dose- DepenDent 
CHanges in alCoHoliC liVeR 
lipiDome aCRoss 13 lipiD 
Classes
A diverse group of liver lipids significantly changed in 
concentration across time and dose in alcohol- fed mice. 
Of the 960 lipid species annotated in the liver, 297 lipid 
species across 13 lipid classes had statistically significant 
differences between controls and alcohol- fed mice at 4 
and 5  weeks as well as significant differences between 
weeks 2 and 5 of the alcohol- fed diet (using FDR 
[Benjamini- Hochberg]- corrected analysis of variance 
[ANOVA] with Tukey post hoc analysis). A large per-
centage (25% or greater) of species within a class of those 
lipid classes shown in Fig. 2 (and Supporting Table S1A) 
all changed in the same manner with continued con-
sumption of alcohol (Fig. 2 is derived from Supporting 
Table S1A,B). For certain lipid species, changes occurred 
in the same direction within a lipid class.
The advantage of mass spectrometry- based lipi-
domics is the identification of fatty acyl constituents 
in intact lipids. As this technique has only gained 
popularity within the last decade, minimal informa-
tion is available about individual intact lipid species 
and their biology. Certain lipid classes contained 
both increasing and decreasing lipid species in sam-
ples from ethanol- fed mice (Fig. 2), including phos-
phatidylethanolamines (PEs) (Supporting Fig. S3A), 
diglycerides (DGs) (Supporting Fig. S3I), sphingo-
myelins (SMs) (Supporting Fig. S3O- P), ceramides 
(Cers) (Supporting Fig. S3Q), and phosphatidylglyc-
erols (PGs). Selected individual lipids with significant 
changes across time and between alcohol- fed and pair- 
fed control mice are shown in Supporting Fig. S3A- S.
Over 10% of long and short chain oxidized tri-
glycerides (OxTGs) increased across all time points, 
and over 85% (Supporting Table S1A) were signifi-
cantly higher than controls for weeks 4 and 5. In 
addition, OxTGs were the only lipid class with over 
10% of species higher in alcohol- fed mouse than 
controls for the first time point (week 2; Fig. 2). 
LipidMatch Flow libraries contain both short chain 
(aldehyde and carboxylic acid terminus) and long 
chain (hydroperoxyl, hydroxyl, ketone, and epoxy) 
oxidized species. OxTGs were found to increase with 
ethanol feeding irrespective of the type of oxidation 
product (Supporting Fig. S3J- L). TGs were not the 
only lipids species to be oxidized following exposure 
to ethanol; certain oxidized glycerophospholipids, for 
example, OxPGs(18:1_18:1[OH]) and oxidized phos-
phatidylcholines (OxPCs)(16:0_18:2[OH]) were also 
observed to increase (Supporting Fig. S3M).
A total of 66% of TGs increased between weeks 
2 and 4, and no TGs changed significantly between 
weeks 4 and 5 of ethanol feeding. A large proportion 
of the TGs in the ethanol- fed group were significantly 
higher compared to the control group after week 2 
(85% of TGs were higher during week 4 and 33% 
were higher during week 5 in the ethanol- fed group 
compared to the control group).
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We found that 37% of PCs from the liver tissue 
had decreased between weeks 2 and 4 and 43% had 
decreased between weeks 4 and 5 in the ethanol group. 
Compared to the control group, the ethanol- fed group 
had 52% of PCs lower during week 4 and 61% of PCs 
lower during week 5.
In the ethanol group, 41% of lysophosphatidylcho-
lines (LPCs) from the liver tissue decreased between 
weeks 2 and 4 and 64% decreased between weeks 4 
and 5. Compared to the control group, the ethanol- 
fed group had 64% of PCs lower during week 4 and 
77% of PCs lower during week 5.
Also in the ethanol group, 20% of lysophosphatidy-
lethanolamines (LPEs) from the liver tissue decreased 
between weeks 2 and 4 and between weeks 4 and 5. 
Compared to the control group, 30% of LPEs in the 
ethanol- fed group were lower during week 4 and 40% 
of LPEs were lower during week 5.
Over 10% of ether lipids (50% ether- TG, 10% 
ether- PC, and 32% ether- PE) from the liver tissue 
significantly increased from week 2 to week 4 in both 
alcohol- fed and control mice, followed by a significant 
decrease from week 4 to week 5 of alcohol- fed mice 
(37% ether- TG, 10% ether- PC, and 14% ether- PE). 
Fig. 2. Percentage of liver and plasma lipids per class significantly up- regulated or down- regulated across time and in comparison to 
controls. Alterations (increases or decreases) in classes of lipids in ethanol- consuming mice are expressed as a categorical percentage 
change relative to levels (i) at previous treatment times (2, 4, or 5 weeks) or (ii) in control mice at the same treatment time. Line direction(s) 
represent the direction of differences between treatment times, whereas the position of colored squares (above or below the circle) indicates 
whether lipids are higher in ethanol- fed mice or controls. Significantly up- regulated and/or down- regulated lipid species were determined 
by an FDR- corrected ANOVA with Tukey post hoc test, with P < 0.05 and a fold change of 1.25 (or 0.8 if lipid levels in ethanol- fed 
mice were lower than controls or previous time points). §Values in parentheses represent the number of species per class annotated by 
LipidMatch Flow for liver and plasma samples, respectively. Abbreviation: AcCar: acylcarnitine.
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The ethanol- fed group had lower ether lipids by the 
end of week 5 compared to the control group (48% 
ether- TGs, 41% ether- PCs, and 32% ether- PEs were 
lower in ethanol- fed mice).
By the end of week 5 of ethanol feeding, all Cers 
and SMs contained 20- 22 carbons in their fatty acyl 
chain, i.e., a 24:1 decrease in alcohol- fed mice.
No major percentage increase or decrease in dia-
cylglycerols was observed across time and dose in the 
ethanol group. However, at week 2, 32% of DGs were 
higher in the ethanol group compared to the control 
group, whereas at week 5, 9% of DGs were higher in 
the ethanol group and 19% of DGs were higher in the 
control group.
There was an increase of 18% of PEs and a decrease 
of 22% of PEs in the ethanol- fed group at week 2. 
In addition, 61% of PGs increased at week 2 in the 
ethanol- fed group, and 30% of PGs were higher than 
the control group at week 2. At week 5, 13% of PGs 
were higher in the control group compared to the 
ethanol- fed group.
lipiD CHanges in plasma anD 
CoRRelations to liVeR lipiDs
While mice generally were separated in principal 
component analysis (PCA) using liver lipid profiles 
according to ethanol treatment versus controls, min-
imal separation was obtained in plasma (Supporting 
Fig. S2). No PCA scores were significant between 
groups for mouse plasma except between GE1 and 
GE2. For mouse liver, the following were significant 
(FDR corrected P < 0.05 using Benjamini- Hochberg): 
chow versus GE1, GC2 versus GE2, GC3 versus GE3, 
GE1 versus GE3, and GE1 versus GE2 (Supporting 
Fig. S2). Observed changes in plasma did not gener-
ally correspond to lipid changes in liver, although cer-
tain lipid species followed similar trends (Fig. 3A- D). 
One OxTG in the plasma, OxTG(18:2_18:2_18:2 
[ketone]), was significantly higher at all time points in 
ethanol- fed versus control mice (Fig. 3B). This species 
was over an order of magnitude higher in the liver at 
both weeks 4 and 5 than in the plasma and showed 
similar trends compared to plasma (Fig. 3A).
Pearson’s correlation across 336 lipids annotated in 
both plasma and liver showed that about 18% of lip-
ids correlated with a Pearson’s value of 0.4 or higher 
and a significant FDR- corrected P value (Benjamini- 
Hochberg corrected), whereas only seven correlated 
with a Pearson’s correlation greater than 0.7. Of 
the lipids with Pearson’s correlation above 0.4, 84% 
consisted of lipids containing at least one fatty acid 
between 20 and 22 carbons in length. Also, lipids cor-
relating between plasma and liver mainly consisted of 
sphingolipids (only those with 20:0 or 22:0), PCs, and 
LPCs. The PCs and LPCs were significantly down- 
regulated in the ethanol- fed mice at 4 and 5 weeks. 
For example, LPC(20:0), which had one of the stron-
gest correlations between plasma and liver (Supporting 
Fig. S8; Pearson’s value, 0.73), was also found to be 
17- fold higher in week- 2 ethanol- fed mice compared 
to the ethanol- fed mice at weeks 4 and 5. This LPC 
was also 16- fold higher in respective controls com-
pared to ethanol- fed mice at weeks 4 and 5. Because 
the plasma levels of these lipids reflect changes in the 
liver, these lipids serve as biomarker candidates for 
ethanol damage to the liver.
Plasma lipid changes in response to alcohol feeding 
appeared to depend on the dose and/or duration of 
alcohol feeding. For example, nearly all lipid classes 
with significant changes in alcohol- fed mice (DG, 
PC, LPC, PE, LPE, TG, ether- TG, SM, and Cer) 
were found to be reduced during weeks 4 and 5. By 
contrast, a few (DG, LPE, TG, and SM) were ele-
vated in week 2 relative to pair- fed controls (Fig. 2). 
One exception to the decrease in lipid classes by week 
4 was acylcarnitine; over 50% of the 17 annotated spe-
cies were elevated in alcohol- fed mice in both weeks 
4 and 5 of feeding (relative to pair- fed control mice) 
(Fig. 1; Supporting Fig. S4C).
The plasma levels of most glycerophospholip-
ids (>50%) were reduced by week 4 (Supporting 
Fig. S5D). Of the decreased glycerophospholipids, 
a large proportion contained 20:4 (Fig. 4D), and 
five of the top six most significantly changed spe-
cies contained 20:4 (Supporting Fig. S4D). The 
fatty acyl trends observed in liver were reproduced in 
plasma, with down- regulated sphingolipids contain-
ing only 20- 22 carbons (except for 24:1) in both liver 
and plasma (Fig. 4A,C). A boxplot for one of the 
most significantly altered sphingolipids in plasma, 
HexCer(d18:1/22:0) (Fig. 3D), is shown alongside 
the corresponding lipid boxplot in liver (Fig. 3C). 
Glycerophospholipids also showed trends in the fre-
quency of fatty acyl chains across down- regulated 
lipids, with these down- regulated lipids in both 
plasma and liver containing mainly 20- 22 carbons 
in the longest fatty acyl chain, with 20:4, 22:6, and 
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Fig. 3. Boxplots of an OxTG and HexCer lipid molecule with significant changes across time and between ethanol- fed and control 
mice. Minimum, first, second, and third quartile and maximum were used to generate boxplots; individual samples are also shown (dots). 
Relative amounts of OxTG(18:2_18:2_18:2[ketone]) in (A) liver and (B) plasma; (C) HexCer(d18:1/22:0) in liver and (D) plasma are 
shown (class- based internal standard normalization applied). Both species show significant changes across time points and between 
alcohol- fed and control (pair- fed) mice. Significance was determined by an FDR (Benjamini- Hochberg)- corrected ANOVA with Tukey 
post- hoc test (P  < 0.05). Groupings with the same letters are not significantly different from one another, whereas those without the 
same letters are. §The peak representing OxTG(18:2_18:2_18:2[ketone]) also consisted of OxTG(16:0_18:2_20:4[ketone]) as a smaller 
fraction. Abbreviations: HexCer, hexosylceramide; wks, weeks.
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22:5 most frequently occurring (Fig. 4B,D). In con-
trast, docosahexaenoic acid (22:6)- containing species 
were the only lipids with 20- 22- carbon chains, with 
a large percentage of species up- regulated as well as 
down- regulated in ethanol- fed mice versus controls 
(Fig. 4).
DoWn- Regulation oF 20- 22 
CaRBons anD 24:1 Fatty aCyl 
CHains in alCoHol- FeD miCe
Sphingolipids are important species for numerous 
biological functions, including signaling related to 
Fig. 4. Number of instances (frequency) of fatty acyl constituents in up- regulated and down- regulated lipids (y axis) in 5 weeks for 
alcohol- fed mice versus controls colored by lipid class. Fatty acyl constituents are shown across the x axis. Lipids contain one or more fatty 
acyl constituent bound to a backbone and head group, and the up- regulation or down- regulation of lipids containing these fatty acids can 
be indicative of the release of these fatty acids for downstream signaling in certain pathways (e.g., inflammatory pathways). The instances 
(frequency) of fatty acyl constituents contained in lipids that were up- regulated (i.e., higher in alcohol- fed mice compared to pair- fed 
controls) or down- regulated (i.e., lower in alcohol- fed mice compared to pair- fed controls) are shown (A) for HexCer, Cer, and SM in 
liver; (B) for DG, PE, and PG in liver; (C) for HexCer, Cer, and SM in plasma; (D) for DG, PE, and PC in plasma samples. Significant 
changes (P < 0.05) between lipids in the alcohol fed- group and the control group were determined by an FDR- corrected (Benjamini- 
Hochberg) ANOVA followed by Tukey post hoc test. For sphingolipids shown in (A), the fatty acyl chain on the sn2 position was used to 
calculate frequencies, whereas for DG, PG, PC, and PE, the longest carbon chain (or both if carbon chain lengths were equal) was used 
for the fatty acyl frequency calculations. On the plot, 0 refers to no significant lipids contained the corresponding fatty acyl constituent. 
Abbreviation: HexCer, hexosylceramide.
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apoptosis, cell differentiation and growth, and inflam-
mation. All sphingolipids that decreased in alcohol- 
fed mice contained 20- 22 carbons in their fatty acyl 
chain or 24:1 (Fig. 4A). By contrast, sphingolipids 
with shorter chains (16- 18 carbons) or longer chains 
(23- 25) increased significantly by week 4 (Figs. 2, 4A). 
For example, for sphingolipids, Cer(d18:3/24:0), 
Cer(d18:1/24:0), Cer(d18:2/24:0), and SM(d18:2/24:0) 
were all significantly up- regulated, and therefore there 
is a frequency of 4 under 24:0 (Fig. 4A). Similarly, 
DGs, PGs, and PEs, which were down- regulated in 
the alcohol- fed group by week 5, all had at least one 
fatty acyl chain with 20- 22 carbons (Fig. 4B). With 
the exception of two of 26 up- regulated species and 
22:6, no up- regulated DG, PE, or PG had 20- 22 car-
bons (Fig. 4B). In addition to certain DGs, PEs, and 
PGs (Fig. 4B) containing 22:6, ether- PE(P- 20:0/22:6) 
was the only ether lipid to increase in alcohol- fed 
mice (the majority decreased by week 5) (Supporting 
Fig. S3E).
Histology anD CoRRelation 
to lipiD pRoFiles
Histology was performed on all tissue sections that 
had lipidomics performed. Evidence of cell injury, 
inflammation, reactive changes, and steatosis was doc-
umented (see Supporting Material and Supporting 
Fig. S1) using published methods.(17) Of these, only 
the total score for steatosis was significantly higher in 
alcohol- fed mice, i.e., in weeks 4 and 5 of alcohol feed-
ing (relative to pair- fed control mice; see Supporting 
Material and Supporting Fig. S1). Histologically, only 
steatosis was significantly higher in alcohol- fed mice 
at week 4 (P = 0.001; mean score ± SD ethanol group, 
0.65 ± 0.034; mean score controls, 0). TG levels fol-
lowed the same trend with over 50% increases in weeks 
4 and 5 of ethanol feeding (Fig. 2). Whereas the use 
of histology was unable to delineate signs of steatosis 
in a number of the week- 4 and week- 5 alcohol- fed 
mice, lipidomics revealed that for certain TGs, such 
as TG(17:0_18:2_22:6), the concentration in every 
alcohol- fed mouse was higher than in pair- fed con-
trols (Supporting Fig. S3F). These results suggest that 
lipidomics may be a more sensitive approach than his-
tology to characterize the development and degree of 
steatosis. In addition, whereas histology only indicated 
that one mouse had signs of steatosis in the week- 5 
control (pair- fed) liquid diet (which contains high- fat 
content by design) mice, lipidomics revealed that for 
numerous TGs, there was a significant increase com-
pared to week- 2 and week- 4 control mice. This reveals 
that lipidomics may also be more sensitive to signs of 
steatosis from a high- fat diet, i.e., identifies changes 
before histological detection is possible.
Discussion
Only limited studies have been conducted on 
chronic alcohol- induced effects on the hepatic lipi-
dome (see review by Clugston et al.(18)). Our study 
is unique compared to previous studies in the use of 
LipidMatch Flow and a time- course experiment that 
provides unprecedented detail on the diversity of lipid 
changes across early stages of liver damage caused by 
alcohol consumption. We provide evidence of hepatic 
inflammation, steatosis, and oxidative damage at early 
stages of alcohol consumption based on lipid changes 
(Figs. 2 and 5) and show that lipidomics is more 
sensitive to pathophysiological changes than histol-
ogy. We also propose mechanisms underlying these 
changes (below).
In the present study, a decrease in both hepatic and 
plasma PC and LPC levels were observed in ethanol- 
fed mice across the three feeding durations (Fig. 2). 
While mice generally were separated in PCA accord-
ing to ethanol treatment using liver lipid profiles, 
minimal separation was obtained in plasma. This sug-
gests that other factors beyond treatment with ethanol 
had a strong effect on the lipid profiles observed in 
plasma. This is expected because the direct target of 
ethanol is the liver whereas the plasma reflects a mix-
ture of lipids from numerous organs.
An explanation for the observed decrease in PC 
is the shift toward synthesis of TGs through initial 
conversion of PCs to DGs. DGs fuel the synthesis 
of TGs during hepatic steatosis. This is supported by 
the up- regulation of DG acyltransferase 2 (DGAT2) 
reported for chronic alcohol consumption, an isoform 
predominantly expressed in the liver that plays a reg-
ulatory role in TG biosynthesis, fatty acid homeosta-
sis, very low- density lipoprotein (VLDL) assembly, 
and positive regulation of hepatic stellate cells.(19,20) 
Interestingly, while histological assessment of liver tis-
sues found no significant difference between steatosis 
in ethanol- treated and control mice except in week 4 
(Supporting Fig. S1; only approaching significance for 
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week 5), significant differences were obtained in lip-
idomic results for TGs in both weeks 4 and 5, show-
ing that use of a lipidomics approach may be a more 
sensitive and accurate tool to identify steatosis than 
histology (Fig. 2).
Sphingolipids play vital roles as regulators of many 
cellular processes, such as cell growth, apoptosis, cell 
senescence, inflammation, and intracellular traffick-
ing, in response to cellular stress.(21) We observed a 
differential decrease and increase in specific SM and 
Cer species, with those containing predominantly 
C20 and C22 fatty acyl chains decreasing after 4 
weeks of ethanol feeding and certain species increas-
ing between weeks 2 and 4 (Fig. 4A). Arachidonic 
acid (20:4) serves as a precursor for proinflammatory 
mediators.(22) As such, 20:4- containing glycerophos-
pholipids may serve as a source of 20:4 for an inflam-
matory response, explaining the decrease. Ethanol 
has been shown to induce increased levels of hepatic 
Cers and increased sphingosine and sphinganine in 
mice, with the latter two being precursors for Cer 
production.(23,24) Sphinganine and sphingosine were 
also found to be increased significantly compared to 
controls in our study. Cer can also be generated from 
SM hydrolysis by acidic sphingomyelinase (Smpd1) 
activity, which is increased by alcohol,(24) although 
corresponding SMs were not up- regulated, suggesting 
the prior route of synthesis. It is, however, import-
ant to note that the regulation of Cer levels is com-
plex and can occur in numerous distinct mechanisms 
depending on organelle location and other signaling 
cascades.(21) Increased hepatic Cer has downstream 
implications for the induction of hepatic steatosis. 
Cer is a known activator of protein phosphatase 2 
through acid sphingomyelinase activation. Increased 
protein phosphatase 2 activity inhibits 5’ adenosine 
monophosphate- activated protein kinase phosphory-
lation, which leads to activation of sterol regulatory 
element- binding protein 1 and acetyl- coenzyme A 
carboxylase. This enhances lipogenesis and depresses 
Fig. 5. Lipid changes in mouse liver determined by LipidMatch Flow indicative of steatosis, oxidative damage, and inflammation in 
ethanol- fed mice. PC is hydrolyzed by three phospholipase enzymes (D, C, and A2) at the plasma membrane. Phospholipase D results in 
the synthesis of phosphatidic acid and choline; phospholipase C results in DG and phosphatidylcholine head group, which is used in SM 
synthesis; and phospholipase A2 forms LPC and fatty acids. DG and LPC are involved in intracellular cellular signaling. DG can undergo 
acylation to form TG (leading to steatosis). TG undergoes further oxidation by ROS to form OxTG. C20 and C22 fatty acids are released 
from various sources, such as DGs, sphingolipids, and PEs. They can undergo oxidation, forming oxylipins and aldehydes. Oxylipins, such 
as eicosanoids, are then used in cellular signaling, such as in the inflammatory pathway. Aldehydes can cause cellular damage or undergo 
further reaction, such as carbonylation to form signaling molecules or dehydrogenation to form acetate.
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fatty acid oxidation, leading to the accumulation of 
TGs in the liver and induction of steatosis.(23,25- 27)
Interestingly, we observed a decreasing trend in 
C20- and C22- containing lipids, both in the sphin-
golipids (Fig. 4A), and from DGs, PEs, and PGs 
(Fig. 4B). The selective reduction in certain C20- and 
C22- containing lipids may be explained by the release 
of the respective fatty acids by lipases to induce an 
inflammatory response through oxylipin synthesis 
(Fig. 5).(28) The decrease in certain C20 and C22 
fatty acyl- containing lipids suggests that these fatty 
acids are used as cellular messengers and signal-
ing molecules in the inflammatory pathways before 
microscopic changes are observed related to inflam-
mation (Supporting Fig. S1). These changes can be 
protective, for example, docosahexaenoic acid (22:6) 
can reduce the inflammatory response and insulin 
resistance,(29) and therefore the increase in some lip-
ids containing 22:6 may be protective if released for 
resolving production.
While PE containing 20- 22 carbons decreased, 
over 10% of species detected were increased by week 5 
(Fig. 2); for PCs, over 50% of species were found to be 
significantly lower by week 5 than in controls, whereas 
no species increased. The concomitant changes in the 
levels of PC and PE have significant implications. 
The ratio of PC to PE influences membrane integ-
rity and plays a role in the progression of steatosis 
to steatohepatitis. In one study, a decreased PC/PE 
ratio led to progression of steatosis to steatohepati-
tis, whereas an increased PC/PE ratio in vivo reversed 
steatohepatitis but not steatosis.(30) The decrease in 
PE may be attributed to oxylipin synthesis, as dis-
cussed before, and to increased conversion of PE to 
PC by the action of PE N- methyltransferase, which 
has higher preference for arachidonic acid- containing 
PEs (which were the most drastically reduced in our 
study) and is shown to increase after short- term alco-
hol treatment.(31) The increased levels of PE species 
not containing C20 and C22 is postulated to be a 
form of compensatory reaction toward depleted PC 
(as discussed before) because PE is the second most 
abundant phospholipid of most cell membranes after 
PC.
Plasmalogens, being the most abundant ether lipid, 
play an important role as endogenous antioxidants due 
to the presence of a vinyl ether bond that is susceptible 
to oxidation and termination of the chain- propagating 
step of oxidative damage to lipid membranes and 
droplets.(32,33) We found that ether lipids (ether- PC, 
ether- PE, and ether- TG) were lower in alcohol- fed 
individuals compared to the control in all groups, with 
over 25% of species increased between weeks 2 and 
4 in ethanol- fed mice. Ethanol metabolism results 
in synthesis of reactive oxygen species (ROS) that 
preferentially oxidize plasmalogen due to the reactive 
vinyl ether bond, consistent with the decrease in the 
alcohol- fed group compared to the control. However, 
we also observed an increase in over 25% of ether- 
linked lipids between weeks 2 and 4. This suggests 
that despite the decrease levels of ether lipids due 
to their role as a sacrificial antioxidant, we postulate 
that there is increased synthesis of ether lipid at the 
peroxisome– endoplasmic reticulum pathway as a pro-
tective response to cellular damage caused by ROS 
during ethanol metabolism. Studies have shown the 
protective role of plasmalogen against hepatic steato-
sis and steatohepatitis in nonalcoholic steatohepatitis 
(NASH).(34,35) This supports our finding of steatosis 
in the setting of low ether lipid level due to oxida-
tive stress damage. However, we did not find studies 
investigating the effects of ethanol on the expres-
sion of genes and enzymes in ether lipid metabolism. 
Interestingly, we also observed a significant decrease 
(over 20- fold) in docosahexaenoic acid (C22:6)- 
containing ether- TGs in the ethanol- fed group 
(Supporting Fig. S7). A decrease in 22:6- containing 
TGs has been shown in steatosis in NASH but not 
in those with simple hepatic steatosis.(35) Along with 
ether- TGs containing 22:6, a number of other lipids 
containing high levels of polyunsaturated fatty acids 
were found to have the lowest correlation coefficient 
versus oxidized lipids (Supporting Fig. S6). Under 
oxidative stress, polyunsaturated fatty acids are pref-
erentially oxidized over monounsaturated fatty acyl- 
containing lipids to form peroxides and aldehydes, 
which are lipotoxic and can modify lipids, proteins, 
carbohydrate, and DNA. Importantly, polyunsaturated 
aldehydes can undergo protein carbonylation, which 
then plays a role in the redox cellular signaling mech-
anism, mitochondrial dysfunction, and endoplasmic 
reticulum stress in response to oxidative stress.(36) One 
of the most sensitive changes in lipids was for OxTGs, 
which are direct products of oxidative stress and were 
found to increase before any other lipid changes were 
observed at the class level (Fig. 2). This suggests 
that certain OxTGs may be sensitive biomarkers in 
liver and plasma of early stage alcohol- induced liver 
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damage (Figs. 2, 3, and 5). It is interesting to note 
that primary, secondary, and tertiary oxidation prod-
ucts were observed, suggesting that lipidomics can be 
used to determine different stages of oxidative damage 
in tissues.
An important future step would be to translate 
observations and mechanistic insights in animal stud-
ies to specific impacts of alcohol on the human liver 
and blood plasma lipidome. Humans undergo similar 
responses to alcohol consumption as observed in mouse 
models; increase hepatic lipogenesis is observed in both 
mouse and humans after alcohol consumption,(37,38) 
and ethanol promotes the formation of lipid droplets 
in the liver and reduces the secretion of VLDL.(39) 
Human studies applying lipidomics to ALD are lack-
ing, but current consensus on multiple model systems 
show an increase in 18- carbon fatty acid- containing 
lipids. Furthermore, lipidomics studies on nonalcoholic 
liver disease in humans show changes in lipids (includ-
ing certain sphingolipids) involved in the inflamma-
tory responses(40) and more direct changes related to 
cell damage, for example, the generation of oxidized 
lipid species.(41) These results in humans align with 
the results from our mouse model where we also show 
fat droplet accumulation by histology (Supporting Fig. 
S1), increases in 18- carbon fatty acid- containing lipids 
(Fig. 4), changes in sphingolipids indicative of inflam-
mation (Fig. 4), and a drastic and early rise in oxidized 
lipids (Fig. 2). Therefore, results in our current study 
both expand on and align with the limited findings 
in human subjects, and more human- based lipidomics 
studies related to AFLD are needed.
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